Gaia Cola
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Skin Thickening of the Scalp and High Signal Intensity of Dentate Nucleus in Multiple Sclerosis: Association With Linear Versus Macrocyclic Gadolinium-Based Contrast Agents Administration.
Journal: Investigative radiology
Published: February 02, 2023
COVID-19 vaccine hesitancy among Italian people with multiple sclerosis.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: September 11, 2022
A specific anti-COVID-19 BNT162b2 vaccine-induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients.
Journal: Clinical & translational immunology
Published: August 08, 2022
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 23, 2022
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 21, 2022
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications.
Journal: Frontiers in immunology
Published: October 16, 2021
Anti-HBs titers are not decreased after treatment with oral Cladribine in patients with Multiple Sclerosis vaccinated against Hepatitis B virus.
Journal: Multiple sclerosis and related disorders
Published: September 21, 2021
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection.
Journal: Multiple sclerosis and related disorders
Published: July 31, 2021
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 19, 2021
T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers.
Journal: Multiple sclerosis and related disorders
Published: June 05, 2021
Patient's point of view on the use of telemedicine in multiple sclerosis: a web-based survey.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: April 15, 2021
Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigation.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 10, 2021
Last Updated: 09/26/2026